13F Filings History of APPLETON GROUP, LLC

Latest 13F report
Q3 2023 - 08 Nov 2023
Value $
$28,634,342
Signature - Title
Karen Anderson - CCO
Location
Appleton, WI
Summary
This page shows a list of all the recent 13F filings made by APPLETON GROUP, LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. APPLETON GROUP, LLC reported 27 stock holdings with total value $28,634,342 as of Q3 2023. Top holdings included SCHD, SCHZ, IJH, IWD, and SPY.

Follow Filing Activity

Follow APPLETON GROUP, LLC and return when a new 13F portfolio filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Holdings Value

Quick Takeaways

  • APPLETON GROUP, LLC reports institutional holdings through Form 13F filings.
  • Latest reported quarter: Q3 2023.
  • Latest reported holdings value: $28,634,342.

What Changed

  • Most recent filing was accepted on 08 Nov 2023, 14:51.
  • Reported value moved from $71,641,598 to $28,634,342.

Why This Matters

  • This gives a plain-language read of holdings direction before you open full quarter tables.
  • Use the filing links below to verify the exact SEC source document.

Source Evidence

Backed by Form 13F

Portfolio holdings and changes are grounded in SEC Form 13F filings.

See Original Filing
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q3 2023 27 $28,634,342 +$17,648,996 -$59,027,216 -$41,378,220 SCHD, SCHZ, IJH, IWD, SPY 13F-HR 08 Nov 2023, 14:51
Q2 2023 37 $71,641,598 +$24,893,720 -$9,484,864 +$15,408,856 SCHG, SCHX, SCHA, IJH, SCHZ 13F-HR 03 Aug 2023, 15:03
Q1 2023 32 $51,290,549 +$23,987,789 -$41,873,590 -$17,885,801 SCHG, SCHX, SCHZ, VCSH, SCHM 13F-HR 09 May 2023, 13:01
Q4 2022 42 $68,185,316 +$49,761,343 -$18,246,302 +$31,515,041 SCHD, SCHX, SCHF, JNK, LQD 13F-HR 02 Feb 2023, 14:13
Q3 2022 22 $35,029,000 +$23,304,183 -$5,402,878 +$17,901,305 SCHM, SCHV, SCHX, SCHZ, VCSH 13F-HR 08 Nov 2022, 15:50
Q2 2022 26 $17,187,000 +$3,608,436 -$48,862,970 -$45,254,534 SCHZ, VCSH, LQD, CWB, SCHM 13F-HR 27 Jul 2022, 14:28
Q1 2022 43 $71,840,000 +$31,319,839 -$43,266,188 -$11,946,349 SCHG, SCHM, SCHV, SCHF, LQD 13F-HR 03 May 2022, 16:29
Q4 2021 51 $99,704,000 +$14,053,680 -$38,716,625 -$24,662,945 SCHG, SCHV, SCHX, JNK, PGX 13F-HR 09 Feb 2022, 12:04
Q3 2021 42 $116,217,000 +$10,610,286 -$23,155,089 -$12,544,803 SCHG, SCHX, SCHV, SCHA, SCHF 13F-HR 15 Nov 2021, 17:20
Q2 2021 51 $130,261,000 +$59,950,685 -$10,453,594 +$49,497,091 SCHG, SCHV, SCHX, SCHF, SCHE 13F-HR 05 Aug 2021, 12:54
Q1 2021 43 $76,469,000 +$12,697,140 -$43,887,296 -$31,190,156 SCHV, SCHX, SCHA, PGX, VCSH 13F-HR 07 May 2021, 15:40
Q4 2020 33 $102,488,000 +$35,643,461 -$4,602,665 +$31,040,796 SCHG, SCHX, SCHV, SCHA, SCHF 13F-HR 05 Feb 2021, 16:29
Q3 2020 29 $63,864,000 +$3,883,484 -$28,723,911 -$24,840,427 SCHG, SCHX, SCHF, CWB, PGX 13F-HR 02 Nov 2020, 13:43
Q2 2020 30 $83,066,000 +$60,342,222 -$899,840 +$59,442,382 SCHG, SCHX, SCHV, SCHA, SCHF 13F-HR 29 Jul 2020, 13:25
Q1 2020 15 $19,814,000 +$484,959 -$48,588,465 -$48,103,506 SCHG, SCHX, SCHZ, JNK, SPY 13F-HR 06 May 2020, 10:11
Q4 2019 33 $78,797,000 +$8,027,961 -$21,165,088 -$13,137,127 SCHG, SCHV, SCHX, SCHA, SCHF 13F-HR 22 Jan 2020, 13:56
Q3 2019 29 $86,127,000 +$8,406,164 -$12,613,939 -$4,207,775 SCHG, SCHX, SCHV, SCHF, SCHA 13F-HR 16 Oct 2019, 12:54
Q2 2019 29 $89,602,000 +$3,546,978 -$20,636,735 -$17,089,757 SCHG, SCHX, SCHV, SCHF, CWB 13F-HR 07 Aug 2019, 10:39
Q1 2019 32 $103,839,000 +$103,839,000 $0 +$103,839,000 SCHG, SCHX, SCHV, SCHF, SCHA 13F-HR 26 Apr 2019, 15:30
Q4 2018 0 $0 $0 -$94,383,000 -$94,383,000 13F-HR 14 Feb 2019, 09:57
Q3 2018 30 $94,383,000 +$17,841,341 -$3,002,695 +$14,838,646 SCHG, SPY, SCHV, SCHA, IWD 13F-HR 13 Nov 2018, 13:17
Q2 2018 26 $76,091,000 +$21,540,912 -$34,267,466 -$12,726,554 SCHG, SPY, SCHA, CWB, PGX 13F-HR 01 Aug 2018, 11:56
Q1 2018 29 $87,020,000 +$6,707,147 -$19,430,308 -$12,723,161 SPY, SCHV, SCHH, SCHA, QQQ 13F-HR 02 May 2018, 13:44
Q4 2017 36 $100,836,000 +$6,510,320 -$1,502,870 +$5,007,450 SPY, SCHF, SCHV, SCHA, QQQ 13F-HR 22 Jan 2018, 12:22
Q3 2017 32 $93,109,000 +$1,666,515 -$195,787 +$1,470,728 SPY, SCHF, SCHV, SCHH, QQQ 13F-HR 03 Nov 2017, 12:43
Q2 2017 30 $88,451,000 +$1,867,758 -$2,209,001 -$341,243 SPY, SCHF, SCHV, SCHH, SCHA 13F-HR 02 Aug 2017, 10:05
Q1 2017 33 $86,552,000 +$12,641,999 -$5,109,937 +$7,532,062 SPY, SCHF, SCHV, SCHH, SCHA 13F-HR 04 May 2017, 11:58
Q4 2016 28 $75,719,000 +$19,049,199 -$27,403,623 -$8,354,424 SPY, SCHV, SCHF, SCHH, SCHA 13F-HR 01 Feb 2017, 12:45
Q3 2016 29 $82,889,000 +$29,826,868 -$9,066,918 +$20,759,950 SPY, IWD, SCHF, QQQ, SCHE 13F-HR 09 Nov 2016, 13:10
Q2 2016 22 $60,028,000 +$12,657,891 -$38,672,964 -$26,015,073 SPY, IWD, QQQ, IYR, IWM 13F-HR 10 Aug 2016, 13:48
Q1 2016 19 $84,226,000 +$32,904,431 -$25,836,784 +$7,067,647 SPY, IWD, QQQ, ACWX, IYR 13F-HR 04 May 2016, 14:02
Q4 2015 16 $76,799,000 +$48,503,463 -$7,096,846 +$41,406,617 QQQ, SPY, IWD, IYR, ACWI 13F-HR 09 Feb 2016, 10:50
Q3 2015 16 $34,176,000 +$17,017,440 -$67,105,225 -$50,087,785 IYR, SPY, IWD, ACWI, DXD 13F-HR 10 Nov 2015, 14:33
Q2 2015 25 $87,903,000 +$3,681,792 -$9,602,738 -$5,920,946 QQQ, SPY, IWD, ACWI, IWM 13F-HR 05 Aug 2015, 13:08
Q1 2015 24 $94,008,000 +$13,120,886 -$3,315,105 +$9,805,781 QQQ, SPY, IWD, ACWI, IWM 13F-HR 06 May 2015, 14:56
Q4 2014 21 $82,617,000 +$18,841,646 -$17,667,588 +$1,174,058 QQQ, IYR, IWD, SPY, ACWI 13F-HR 10 Feb 2015, 10:17
Q3 2014 25 $68,708,000 +$2,209,995 -$11,342,691 -$9,132,696 SPY, QQQ, IYR, VWO, IJH 13F-HR 04 Nov 2014, 11:33
Q2 2014 26 $90,051,000 +$9,689,272 -$4,687,444 +$5,001,828 IWD, SPY, ACWI, IYR, QQQ 13F-HR 06 Aug 2014, 11:20
Q1 2014 25 $81,476,000 +$7,562,912 -$3,424,350 +$4,138,562 QQQ, IWD, SPY, ACWI, IYR 13F-HR 13 May 2014, 15:39
Q4 2013 16 $75,844,000 $0 $0 $0 QQQ, IWD, SPY, ACWI, IYR 13F-HR 05 Feb 2014, 10:30
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .